170 related articles for article (PubMed ID: 14979500)
21. Haemodynamic effects of short-term nasal continuous positive airway pressure therapy in sleep apnoea syndrome: monitoring by a finger arterial pressure device.
Sforza E; Capecchi V; Lugaresi E
Eur Respir J; 1992 Jul; 5(7):858-63. PubMed ID: 1499711
[TBL] [Abstract][Full Text] [Related]
22. Reduced cardiac sympathetic autonomic tone after long-term nasal continuous positive airway pressure in obstructive sleep apnoea syndrome.
Roche F; Court-Fortune I; Pichot V; Duverney D; Costes F; Emonot A; Vergnon JM; Geyssant A; Lacour JR; Barthélémy JC
Clin Physiol; 1999 Mar; 19(2):127-34. PubMed ID: 10200894
[TBL] [Abstract][Full Text] [Related]
23. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial.
Jenkinson C; Davies RJ; Mullins R; Stradling JR
Lancet; 1999 Jun; 353(9170):2100-5. PubMed ID: 10382693
[TBL] [Abstract][Full Text] [Related]
24. Optimizing the Management of Uncontrolled/Resistant Hypertension. The Importance of Sleep Apnoea Syndrome.
Wolf J; Narkiewicz K
Curr Vasc Pharmacol; 2017; 16(1):44-53. PubMed ID: 28413970
[TBL] [Abstract][Full Text] [Related]
25. Acute effects of nasal continuous positive airway pressure on 24-hour blood pressure and catecholamines in patients with obstructive sleep apnea.
Minemura H; Akashiba T; Yamamoto H; Akahoshi T; Kosaka N; Horie T
Intern Med; 1998 Dec; 37(12):1009-13. PubMed ID: 9932630
[TBL] [Abstract][Full Text] [Related]
26. Effect of treatment with nasal continuous positive airway pressure on ventilatory response to hypoxia and hypercapnia in patients with sleep apnea syndrome.
Spicuzza L; Bernardi L; Balsamo R; Ciancio N; Polosa R; Di Maria G
Chest; 2006 Sep; 130(3):774-9. PubMed ID: 16963674
[TBL] [Abstract][Full Text] [Related]
27. [Nasal continuous positive airway pressure (nCPAP) therapy in obstructive sleep breathing disorders].
Becker H; Stammnitz A; Schneider H; Peter JH; von Wichert P
Dtsch Med Wochenschr; 1995 Jun; 120(22):783-9. PubMed ID: 7781509
[TBL] [Abstract][Full Text] [Related]
28. Effect of short term graded withdrawal of nasal continuous positive airway pressure on systemic blood pressure in patients with obstructive sleep apnoea.
Stradling JR; Partlett J; Davies RJ; Siegwart D; Tarassenko L
Blood Press; 1996 Jul; 5(4):234-40. PubMed ID: 8809375
[TBL] [Abstract][Full Text] [Related]
29. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea.
Becker HF; Jerrentrup A; Ploch T; Grote L; Penzel T; Sullivan CE; Peter JH
Circulation; 2003 Jan; 107(1):68-73. PubMed ID: 12515745
[TBL] [Abstract][Full Text] [Related]
30. nCPAP treatment interruption in OSA patients.
Fiz JA; Abad J; Ruiz J; Riera M; Izquierdo J; Morera J
Respir Med; 1998 Jan; 92(1):28-31. PubMed ID: 9519221
[TBL] [Abstract][Full Text] [Related]
31. Required levels of nasal continuous positive airway pressure during treatment of obstructive sleep apnoea.
Sériès F; Marc I; Cormier Y; La Forge J
Eur Respir J; 1994 Oct; 7(10):1776-81. PubMed ID: 7828684
[TBL] [Abstract][Full Text] [Related]
32. Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome.
Shimizu K; Chin K; Nakamura T; Masuzaki H; Ogawa Y; Hosokawa R; Niimi A; Hattori N; Nohara R; Sasayama S; Nakao K; Mishima M; Nakamura T; Ohi M
Thorax; 2002 May; 57(5):429-34. PubMed ID: 11978920
[TBL] [Abstract][Full Text] [Related]
33. [Continuous noninvasive blood pressure measurement in obstructive sleep apnea syndrome without and with CPAP therapy].
Kellner C; Kirchheiner T; Rühle KH
Pneumologie; 1993 Mar; 47 Suppl 1():178-80. PubMed ID: 8497475
[TBL] [Abstract][Full Text] [Related]
34. Wrist-actigraphic estimation of sleep time under nCPAP treatment in sleep apnoea patients.
Gagnadoux F; Nguyen XL; Rakotonanahary D; Vidal S; Fleury B
Eur Respir J; 2004 Jun; 23(6):891-5. PubMed ID: 15219003
[TBL] [Abstract][Full Text] [Related]
35. Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome.
Christou K; Kostikas K; Pastaka C; Tanou K; Antoniadou I; Gourgoulianis KI
Sleep Med; 2009 Jan; 10(1):87-94. PubMed ID: 18077211
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of an auto-nCPAP device based on snoring detection.
Lofaso F; Lorino AM; Duizabo D; Najafi Zadeh H; Theret D; Goldenberg F; Harf A
Eur Respir J; 1996 Sep; 9(9):1795-800. PubMed ID: 8880093
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure.
Usui K; Bradley TD; Spaak J; Ryan CM; Kubo T; Kaneko Y; Floras JS
J Am Coll Cardiol; 2005 Jun; 45(12):2008-11. PubMed ID: 15963401
[TBL] [Abstract][Full Text] [Related]
38. Sleep fragmentation indices as predictors of daytime sleepiness and nCPAP response in obstructive sleep apnea.
Bennett LS; Langford BA; Stradling JR; Davies RJ
Am J Respir Crit Care Med; 1998 Sep; 158(3):778-86. PubMed ID: 9731004
[TBL] [Abstract][Full Text] [Related]
39. Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients.
Suzuki M; Otsuka K; Guilleminault C
Sleep; 1993 Sep; 16(6):545-9. PubMed ID: 8235239
[TBL] [Abstract][Full Text] [Related]
40. Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep.
Parati G; Di Rienzo M; Bonsignore MR; Insalaco G; Marrone O; Castiglioni P; Bonsignore G; Mancia G
J Hypertens; 1997 Dec; 15(12 Pt 2):1621-6. PubMed ID: 9488213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
